News - Vaccines

Filter

Current filters:

Vaccines

Popular Filters

176 to 200 of 258 results

PDUFA Action Date for Astellas enzalutamide; Urogenix facility to close

07-08-2012

The US Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date…

Astellas PharmaenzalutamideGenito-urinaryMedivationOncologyPharmaceuticalRegulationResearchUrogenixVaccines

Silencing investor concerns? Alnylam achieves RNAi milestone

02-08-2012

US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) has received a $3.2 million milestone…

Alnylam PharmaceuticalsAnti-viralsBiotechnologyFinancialGlaxoSmithKlineLicensingProductionVaccines

UK to implement child flu vaccines program

25-07-2012

UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…

Anti-viralsAstraZenecaFluenzHealthcarePharmaceuticalVaccines

Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations

25-07-2012

French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Vivalis in new EB66 cell line deal with Merial

18-07-2012

France-based Vivalis (NYSE Euronext: VLS) announced today that it has executed a new research license…

EB66LicensingMerialPharmaceuticalSanofiVaccinesVivalis

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season

17-07-2012

The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

Novavax and Cadila in public/private malaria vaccine collaboration

17-07-2012

USA-based clinical-stage firm Novavax (Nasdaq: NVAX), CPL Biologicals (CPLB) - a joint-venture biotechnology…

Cadila PharmaceuticalsCPL BiologicalsNovavaxPharmaceuticalResearchTropical diseasesVaccines

Australia extends HPV vaccine to schoolboys

12-07-2012

In what is claimed "a world first" by the Department of Health and Ageing, Australian schoolboys will…

Asia-PacificGardasilHealthcareMerck & CoOncologyPharmaceuticalVaccines

Single silk device can store and deliver vaccine or antibiotic without costly cold chain

10-07-2012

Researchers at the USA-based Tufts University School of Engineering have discovered a way to maintain…

Antibiotics and Infectious diseasesPharmaceuticalResearchVaccines

New vaccine uptake drives market growth in India

10-07-2012

In India, the government-sponsored Universal Immunization Program procures vaccines at very low prices,…

Asia-PacificMarkets & MarketingPharmaceuticalVaccines

Bilthoven Biologicals acquired by Serum Institute of India

06-07-2012

Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

CSL Biotherapies indentifies likely reason for Fluvax problems

21-06-2012

Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

Batch of mixed opinions from FDA advisory panels

21-06-2012

Advisory panels of the US Food and Drug Administration meeting yesterday came back with a mixture of…

carfilzomibKyprolisMerck & CoNorth AmericaOncologyOnyx PharmaceuticalsPfizerPharmaceuticalPneumovaxPrevnarRegulationSanofisemuloparinVaccines

US HHS creates new centers to develop, manufacture medical countermeasures

19-06-2012

The US Department of Health and Human Services this week established three new centers to develop and…

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalResearchVaccines

FDA approves GlaxoSmithKline's new combo vaccine MenHibrix

18-06-2012

The US Food and Drug Administration has approved US pharma giant GlaxoSmithKline's (LSE: GSK) MenHibrix…

GlaxoSmithKlineMenHibrixNorth AmericaPharmaceuticalRegulationVaccines

OPKO Health to acquire 45% stake in Israeli hepatitis B vaccine maker

06-06-2012

Miami, USA-based OPKO Health (NYSE: OPK) has entered into a definitive agreement to acquire a 45% stake…

FDS PharmaMergers & AcquisitionsOPKO HealthPharmaceuticalSci-B-VacSciGenVaccines

GlaxoSmithKline plans vaccines and cancer drugs production in Kazakhstan

06-06-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has signed a cooperation agreement with the government of…

EuropeGlaxoSmithKlineMarkets & MarketingOncologyPharmaceuticalVaccines

AFFiRiS starts first clinical trial with Parkinson's vaccine candidate PD01A

06-06-2012

The worldwide first clinical trial for the development of a Parkinson's vaccine has now been started…

AFFiRiSNeurologicalPD01APharmaceuticalResearchVaccines

US government adds $32 million to Bavarian Nordic Imvamune contract

22-05-2012

Denmark's Bavarian Nordic (Nasdaq OMX: BAVA) says that the US Department of Health and Human Services…

Bavarian NordicFinancialImvamuneNorth AmericaPharmaceuticalResearchVaccines

New Global Vaccine Action Plan does not go far enough, says MSF

18-05-2012

A new, 10-year, multi-billion dollar action plan for global vaccination may fail to deliver if it does…

GlobalHealthcarePharmaceuticalVaccines

Biovest to file for EU approval of BiovaxID, a personalized cancer vaccine

16-05-2012

USA-based Biovest International (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals…

BiovaxIDBiovest InternationalEuropeOncologyPharmaceuticalRegulationVaccines

EU Commission clears 23 million-euro R&D aid to Novartis Italy for vaccines in developing countries

08-05-2012

The European Commission has concluded that 23 million euros ($30.2 million) public funding, which Italy…

FinancialNovartisPharmaceuticalResearchVaccines

Vaccines collaborations by Biovest and US Army and by ARTES and Crucell

24-04-2012

USA-based Biovest International (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals…

ARTES BiotechnologyBiotechnologyBiovest InternationalCrucellJohnson & JohnsonResearchVaccines

176 to 200 of 258 results

Back to top